| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/23/2007 | CN1317299C Photoprotein with improved bioluminescence |
| 05/23/2007 | CN1317298C Extraction method and uses of traditional Chinese medicine cassia seed protein |
| 05/22/2007 | US7220902 seed, plants and plant parts produced by crossing inbred maize lines, hybrid maize with another maize plant; producing a maize plant containing in its genetic material one or more traits introgressed into 38F33 through backcross conversion and/or transformation |
| 05/22/2007 | US7220901 Hybrid maize plant and seed 35T06 |
| 05/22/2007 | US7220900 Plants and seeds or corn variety I180581 |
| 05/22/2007 | US7220899 Increasing the total free amino acid content of a plant or transformed progeny by transforming a plant with a plant transformation vector of an isolated polynucleotide encoding a plastidial ATP/ADP translocator,determining the free amino acid content of the transformed plant |
| 05/22/2007 | US7220896 Pyrophosphatase stress-related proteins and methods of use in plants |
| 05/22/2007 | US7220895 Methods and compositions for directing expression of a heterologous nucleic acid in plants |
| 05/22/2007 | US7220894 used to enhance tissue culture response, induce somatic embryogenesis, induce apomixis, increase transformation efficiency or increase recovery of regenerated plants; genetic engineering |
| 05/22/2007 | US7220892 Transgenic mouse lacking PAPP-A activity |
| 05/22/2007 | US7220891 Feline bronchioloalveolar lung carcinoma xenograft and cell line |
| 05/22/2007 | US7220851 Nucleic acid encoding calcyon, a D-1 like dopamine receptor activity modifying protein |
| 05/22/2007 | US7220845 Nucleic acid molecules associated with plant cell proliferation and growth and uses thereof |
| 05/22/2007 | US7220840 Antibodies that immunospecifically bind to B lymphocyte stimulator protein |
| 05/22/2007 | US7220838 Antibodies that specifically bind hedgehog-derived polypeptides |
| 05/22/2007 | US7220835 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 05/22/2007 | US7220834 FHIT proteins and nucleic acids and methods based thereon |
| 05/22/2007 | US7220832 Dermacentor variabilis GABA-gated chloride channels |
| 05/22/2007 | US7220830 Polypeptide underexpressed in stomach tumors |
| 05/22/2007 | US7220829 Cytokine binding domain of cytokine receptors |
| 05/22/2007 | US7220828 Haemopoietin receptor and genetic sequence encoding same |
| 05/22/2007 | US7220826 HIV immunogen; DNA vaccines; amino acid sequences |
| 05/22/2007 | US7220823 A 710 amino acid protein containing 13 transmembrane domains and bearing homology to murine and C. elegans genes containing 12 transmembrane domains |
| 05/22/2007 | US7220822 CD28 mimetics for blocking T cell mediated immune reactions |
| 05/22/2007 | US7220728 Administering by topical or lavage administration to mucosal tissue nucleic acid molecule that comprises a nucleotide sequence that either encodes a desired peptide or protein |
| 05/22/2007 | US7220724 Contortrostatin CN and methods for its use in preventing metastasis and other conditions |
| 05/22/2007 | US7220723 Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
| 05/22/2007 | US7220722 Lipoprotein-regulating medicants |
| 05/22/2007 | US7220721 Exendin agonist peptides |
| 05/22/2007 | US7220719 Using recombinant zinc finger proteins; use in human therapeutic applications such as cancer therapy and altering plant phenotypes, including disease resistance, fruit ripening |
| 05/22/2007 | US7220717 Administering formulation comprising polypeptide and muteins; For immunoregulation and/or treatment of inflammation; muteins, |
| 05/22/2007 | US7220587 Ethylene insensitive plants |
| 05/22/2007 | US7220585 Transcription factor stress-related polypeptides and methods of use in plants |
| 05/22/2007 | US7220583 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof |
| 05/22/2007 | US7220581 Comprises nucleotide sequences coding PAPAP polypeptide for diagnosing and treating psychological and nervous system disorders; drug screening |
| 05/22/2007 | US7220580 Use in diagnosis and treatment of certain lymphoproliferative, neurodegenerative and autoimmune diseases such as large granular lymphocyte leukemia (LGL) |
| 05/22/2007 | US7220579 Identification of the gene causing the mouse scurfy phenotype and its human ortholog |
| 05/22/2007 | US7220577 Modified AAV |
| 05/22/2007 | US7220576 Methods and compositions for protein expression and purification |
| 05/22/2007 | US7220575 Melanoma differentiation associated gene-5 and promoter and uses thereof |
| 05/22/2007 | US7220572 Transgenic eschrichia for fermenting leucine for use in animal feeds, cosmetics and medicines |
| 05/22/2007 | US7220570 polynucleotide encoding a polypeptide having 3-dehydroquinate synthase activity; vector and host cell transformed with said polynucleotide |
| 05/22/2007 | US7220569 Nucleic acids encoding factor X analogues having a modified protease cleavage site |
| 05/22/2007 | US7220568 Nucleic acids encoding the PRO1561 polypeptide |
| 05/22/2007 | US7220567 Isolation of Micromonospora carbonacea var africana pMLP1 integrase and use of integrating function for site-specific integration into Micromonospora halophitica and Micromonospora carbonacea chromosome |
| 05/22/2007 | US7220562 Preparation of (E)- and (Z)-2-methyl-2-butenoic acids |
| 05/22/2007 | US7220558 Bone repair; animal extract in matrix |
| 05/22/2007 | US7220557 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative disorders |
| 05/22/2007 | US7220554 Using transgenic cell expressing viral infectivity factor and cytidine deaminase as tools in identifying modulators of viral infection; viricides; peptide mimetics; enzyme inhibitors |
| 05/22/2007 | US7220546 Methods for diagnosing glaucoma and discovering anti-glaucoma drugs |
| 05/22/2007 | US7220545 Peptide fragment of respiratory syncytial virus protein G, immunogenic agent, pharmaceutical composition containing it and preparation method |
| 05/22/2007 | US7220423 Using a genetic vaccine that codes for conserved domains 2, 3 and 5 of a major outer membrane protein (MOMP) of a strain of Chlamydia; protection against lung infections from the strain of Chlamydia trachomatis for example |
| 05/22/2007 | US7220421 Moraxella bovis cytotoxin, cytotoxin gene, antibodies and vaccines for prevention and treatment of Moraxella bovis infections |
| 05/22/2007 | US7220420 Hepatitis C virus-derived peptides capable of inducing cytotoxic T lymphocyte responses |
| 05/22/2007 | US7220419 Self-assembling recombinant papillomavirus capsid proteins |
| 05/22/2007 | US7220418 Delivery of trefoil peptides |
| 05/22/2007 | US7220415 Vaccine composition |
| 05/22/2007 | US7220405 Peptide-based conditioners and colorants for hair, skin, and nails |
| 05/22/2007 | US7220402 Alpha-fetoprotein peptides and uses for imaging |
| 05/22/2007 | US7220309 Receptor linked protein tyrosine phosphatases |
| 05/22/2007 | CA2524619A1 Novel stem cells, nucleotide sequences and proteins therefrom |
| 05/22/2007 | CA2242562C Human dnase resistant to actin inhibition |
| 05/22/2007 | CA2237983C Non-invasive localization of a light-emitting conjugate in a mammal |
| 05/22/2007 | CA2143187C Anti-feline immunodeficiency virus (fiv) vaccines |
| 05/22/2007 | CA2111645C Fibrinogen fragment e peptides and antibodies thereto |
| 05/22/2007 | CA2110518C Ctla4 receptor, fusion proteins containing it and uses thereof |
| 05/22/2007 | CA2100559C Domains of extracellular region of human platelet derived growth factor receptor polypeptides |
| 05/22/2007 | CA2073045C A human t cell reactive feline protein (trfp) isolated from house dust and uses therefor |
| 05/22/2007 | CA2009917C Cold shock protein, gene coding therefor, promoter for gene encoding cold shock and other proteins, methods and uses as antifreeze protein in agriculture and other applications |
| 05/18/2007 | WO2007056614A1 Gene therapy for renal failure |
| 05/18/2007 | WO2007056398A2 Chlamydia trachomatis specific oligonucleotide sequences |
| 05/18/2007 | WO2007056195A2 Surfactant protein-d for prevention and treatment of lung infections and sepsis |
| 05/18/2007 | WO2007056174A2 Transgenic mouse for elucidating the function of alpha1-adrenergic receptors |
| 05/18/2007 | WO2007056043A2 Use of potassium channels for identifying compounds that have an insecticidal effect |
| 05/18/2007 | WO2007055996A2 Compositions, reagents and kits for and methods of diagnosing, monitoring and treating hormonal imbalance |
| 05/18/2007 | WO2007055952A2 Process for producing stable hiv th-ctl peptides |
| 05/18/2007 | WO2007055636A1 Single nucleotide polymorphisms in the ckrx gene associated with respiratory disease |
| 05/18/2007 | WO2007055369A1 Membrane molecule expressed specifically in activated plasmacytoid dendritic cell |
| 05/18/2007 | WO2007054820A2 Manufacture of vaccines that contain both hepatitis b virus surface antigen and surfactant |
| 05/18/2007 | WO2007054814A1 Inhibitors of parp activity and uses thereof |
| 05/18/2007 | WO2007054792A1 Chimaeric hiv-1 subtype c gag-virus-like particles |
| 05/18/2007 | WO2007054785A1 Mu-conotoxin peptides and use thereof as a local anesthetic |
| 05/18/2007 | WO2007054658A1 Control of immune responses |
| 05/18/2007 | WO2007054522A1 Plants having improved growth characteristics and a method for making the same |
| 05/18/2007 | WO2007054516A1 Productivity augmenting protein factor, novel cell lines and uses thereof |
| 05/18/2007 | WO2007054310A2 Pyroglue |
| 05/18/2007 | WO2007054120A1 Identification and characterization of function-blocking anti-ed-b-fibronectin antibodies |
| 05/18/2007 | WO2007054090A1 Therapeutic vaccines targeting hmgb1 |
| 05/18/2007 | WO2007054034A1 Uses of laccase |
| 05/18/2007 | WO2007054030A1 Polyethylene glycol modifications of thymosin alpha-1 |
| 05/18/2007 | WO2007053974A1 A protein related to plant growth and stress resistance, its coding genes and the use thereof |
| 05/18/2007 | WO2007053952A1 Platelet factor-4 (pf-4) analogs and their use |
| 05/18/2007 | WO2007033140A3 Prok2 antagonists and methods of use |
| 05/18/2007 | WO2007031334A3 Vaccines comprising truncated hbc core protein plus saponin-based adjuvants |
| 05/18/2007 | WO2007031081A3 RNA ANTAGONIST COMPOUNDS FOR THE INHIBITION OF APO-Bl00 EXPRESSION |
| 05/18/2007 | WO2007030637A9 Hiv gp120 crystal structure and its use to identify immunogens |
| 05/18/2007 | WO2007027463A3 Method and system for extracting blood-derived growth factors |
| 05/18/2007 | WO2007025705A3 Method for the generation of antigen-specific t-cells and uses thereof |
| 05/18/2007 | WO2007019266A3 Killing human lymphoma and leukemia cancer cells and tcr-activated normal human cells by dopamine d1r agonists |
| 05/18/2007 | WO2007013882A3 In vitro model for hepatitis c virion production |